# ADJUVANT COMPARISON AND CHARACTERIZATION

> **NIH NIH N01** · STANFORD UNIVERSITY · 2024 · $3,018,059

## Abstract

The goal of the Adjuvant Comparison and Characterization (ACC) program is to support side-by-side comparison of adjuvants in combination with clinically relevant vaccine/antigen platforms, and to establish both systemic and tissue-specific immunological profiles (“immune fingerprints”) of adjuvants that work through different mechanisms in the context of SARS-CoV-2 (COVID-19) vaccines.

## Key facts

- **NIH application ID:** 11159356
- **Project number:** 75N93022C00052-P00004-9999-1
- **Recipient organization:** STANFORD UNIVERSITY
- **Principal Investigator:** BALI PULENDRAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $3,018,059
- **Award type:** —
- **Project period:** 2022-09-01 → 2027-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11159356

## Citation

> US National Institutes of Health, RePORTER application 11159356, ADJUVANT COMPARISON AND CHARACTERIZATION (75N93022C00052-P00004-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11159356. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*